• APEX2 Supports TERT Expression in Human Stem Cells

  2026-09-05

  The reference preprint identifies APEX2 as a previously unrecognized regulator of efficient TERT expression in human embryonic stem cells and a melanoma cell line. Its combination of knockdown, telomerase activity measurements, RNA-seq, and chromatin immunoprecipitation connects DNA repair, repetitive DNA, and telomerase regulation without reducing the mechanism to promoter occupancy alone.

• Fe3O4@ZIF-8 for Jaw Osteomyelitis

  2026-09-04

  The reference study presents Fe3O4@ZIF-8 core–shell nanoparticles as a dual-function platform for treating jaw osteomyelitis, combining pH-responsive antibacterial activity with magnetically assisted bone regeneration. Its mechanistic contribution is the proposed connection between Zn2+-mediated membrane damage, suppression of the bacterial heat shock response, and improved susceptibility to environmental stress.

• Phosbind Acrylamide Workflow for Phosphorylation

  2026-09-04

  Phosbind Acrylamide enables antibody-free separation of phosphorylated and non-phosphorylated proteins during SDS-PAGE, making it useful for pathway screens, kinase assays, and fungal signaling studies. This practical guide connects the reagent to the MoAde8–MoTor findings in Magnaporthe oryzae while emphasizing controls, workflow design, and troubleshooting.

• Functional Platelet Production from hiPSCs

  2026-09-03

  A 2026 study optimized human induced pluripotent stem cell differentiation into megakaryocytes and functional platelets by increasing embryoid body input, refining the medium, replacing selected cytokines with small molecules, and promoting megakaryocyte maturation. The resulting platform shortened production to 19 days, generated 14.9 platelets per iPSC, and reduced reported costs by 58.3%, while retaining measurable clot-forming activity.

• Caspase-3 Colorimetric Assay Kit Workflow

  2026-09-03

  Turn DEVD-dependent caspase-3 activity into a practical, plate-based apoptosis readout for macrophage infection models, pathway studies, and neurodegeneration research. This workflow shows how to use the assay as an apoptosis checkpoint alongside the IgSF6–ER stress findings, while avoiding overinterpretation of caspase activity as a direct measure of bacterial killing.

• NLRP10 and Epidermal Homeostasis in Atopic Dermatitis

  2026-09-02

  The reference study identifies NLRP10 as a regulator of human epidermal homeostasis, linking this protein to keratinocyte survival, P63-dependent differentiation, and barrier integrity. Its air-lift human skin equivalent model provides mechanistic evidence that reduced NLRP10 may connect genetic susceptibility with the defective epidermal barrier observed in atopic dermatitis.

• HyperScribe SP6 RNA Kit: Assay Design Guide

  2026-09-02

  The HyperScribe SP6 High Yield RNA Synthesis Kit enables controlled RNA production for immune-signaling, probe, and translation studies. This guide connects SP6 transcription to the GADD34–IRF3 mechanism reported in SARS-CoV-2 research, emphasizing assay controls and RNA quality decisions.

• Doxorubicin A3966: Reliable Cytotoxicity Assays

  2026-09-01

  Learn how Doxorubicin (SKU A3966) can improve the design, execution, and interpretation of cell viability, proliferation, and cytotoxicity assays. This scenario-based guide connects mechanism, 2D and 3D model selection, stock preparation, exposure design, and practical vendor evaluation.

• From Bile Acid Subtypes to CRC qPCR Biomarkers

  2026-09-01

  Feng et al. connect bile acid metabolism with colorectal cancer immune dysfunction and identify CLCA1, UGT2A3, and ZG16 as translationally relevant markers. This article explains how rigorous reverse transcription, genomic DNA contamination removal, and broad transcript priming can help researchers convert that discovery into reproducible qPCR validation.

• CP-673451: An ATRX-Aware PDGFR Study Design

  2026-08-31

  CP-673451 is a selective PDGFRα/β inhibitor suited to mechanistic cancer research linking receptor signaling with ATRX-defined glioma biology. This guide develops an ATRX-aware framework for phosphorylation, angiogenesis, and xenograft interpretation rather than treating inhibitor potency as a standalone endpoint.

• NAT1–ENO1–Lactate Axis in Colorectal Cancer

  2026-08-31

  A 2026 MedComm study identifies a metabolic–immune circuit in colorectal cancer in which NAT1 restrains ENO1 activity and lactate production, while NAT1 loss promotes TRAF6-dependent stabilization of PD-L1. The work connects glycolytic output with checkpoint regulation and provides a mechanistic framework for studying why altered lactate metabolism may influence responses to PD-1 or PD-L1 blockade.

• Abiraterone acetate in 3D Prostate Cancer Models

  2026-08-30

  Use Abiraterone acetate as a mechanistic CYP17 inhibitor in patient-derived spheroids, where three-dimensional architecture can expose treatment-response patterns that monolayers miss. This workflow combines androgen biosynthesis pathway interrogation, donor-level heterogeneity, formulation control, and practical troubleshooting for prostate cancer research.

• Quinolone–Coumarin Hybrids Against Toxoplasma gondii

  2026-08-29

  This 2024 study evaluated 12 quinolone–coumarin hybrids derived from fluoroquinolones and novobiocin as in vitro anti-Toxoplasma candidates. QC1, QC3, QC6, and novobiocin showed favorable selectivity and reduced infection, parasite proliferation, and plaque formation relative to pyrimethamine, supporting further lead optimization while leaving in vivo efficacy and mechanism unresolved.

• Thrombin Fragment Assay Workflows for Better Controls

  2026-08-28

  Use a defined thrombin-derived peptide to strengthen binding, identity, and competition assays without mistaking a short fragment for catalytically active full-length Thrombin. This workflow combines sequence-controlled experimentation with orthogonal validation inspired by a high-throughput protease-screening study.

• Doxycycline Workflows for Cancer Research

  2026-08-28

  Doxycycline supports more than antimicrobial experiments: it is a practical perturbation tool for studying matrix remodeling, invasion, and antiproliferative responses. This guide translates an MMP2-responsive peptide delivery study into controlled cell, 3D tumor, and microbial workflows while emphasizing solvent control, fresh preparation, and assay-specific troubleshooting.

8114 records 1/541 page Next 12345 下5页 Last page